Impact of Non-Small-Cell Lung Cancer-Not Otherwise Specified Immunophenotyping on Treatment Outcome

Tumors with an IHC profile ADC-like had an OS comparable with that of morphological ADCs. These findings support the use of IHC to optimize lung cancer histological typing and therapy.